Louise Burke

1.2k total citations
52 papers, 765 citations indexed

About

Louise Burke is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Louise Burke has authored 52 papers receiving a total of 765 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Louise Burke's work include Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Diagnosis and Treatment (7 papers) and Medical Imaging and Pathology Studies (6 papers). Louise Burke is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Diagnosis and Treatment (7 papers) and Medical Imaging and Pathology Studies (6 papers). Louise Burke collaborates with scholars based in Ireland, United Kingdom and United States. Louise Burke's co-authors include Françoise Galateau-Sallé, Curtis C. Harris, William P. Bennett, Akihiko Gemma, J Vignaud, Khan Ma, William D. Travis, Richard Attanoos, Marian V. Fleming and Guy Launoy and has published in prestigious journals such as Gut, Clinical Cancer Research and Thorax.

In The Last Decade

Louise Burke

49 papers receiving 743 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Louise Burke Ireland 15 386 200 198 108 104 52 765
Nadine Francotte France 14 352 0.9× 208 1.0× 177 0.9× 53 0.5× 128 1.2× 22 675
Pietro Micheli Italy 16 204 0.5× 293 1.5× 267 1.3× 91 0.8× 59 0.6× 20 790
Arrigo Bondi Italy 16 255 0.7× 175 0.9× 228 1.2× 51 0.5× 94 0.9× 45 899
Richard Cheney United States 14 259 0.7× 232 1.2× 307 1.6× 27 0.3× 51 0.5× 33 755
Amanda J. Murphy Canada 14 182 0.5× 212 1.1× 156 0.8× 71 0.7× 32 0.3× 20 773
Yasuyuki Mizutani Japan 18 255 0.7× 215 1.1× 356 1.8× 138 1.3× 23 0.2× 90 863
Elena Gallo Italy 13 154 0.4× 101 0.5× 91 0.5× 201 1.9× 97 0.9× 23 648
Matsuyoshi Maeda Japan 16 236 0.6× 159 0.8× 161 0.8× 30 0.3× 118 1.1× 54 682
Michael Goldfischer United States 8 444 1.2× 433 2.2× 109 0.6× 42 0.4× 51 0.5× 13 658
Felicitas Oberndorfer Austria 14 184 0.5× 258 1.3× 169 0.9× 52 0.5× 25 0.2× 45 720

Countries citing papers authored by Louise Burke

Since Specialization
Citations

This map shows the geographic impact of Louise Burke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louise Burke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louise Burke more than expected).

Fields of papers citing papers by Louise Burke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Louise Burke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louise Burke. The network helps show where Louise Burke may publish in the future.

Co-authorship network of co-authors of Louise Burke

This figure shows the co-authorship network connecting the top 25 collaborators of Louise Burke. A scholar is included among the top collaborators of Louise Burke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louise Burke. Louise Burke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Iacucci, Marietta, Irene Zammarchi, Giovanni Santacroce, et al.. (2025). Detection, localisation, and quantification of neutrophils to assess disease activity and early response to therapy in ulcerative colitis: a novel AI-driven model. EClinicalMedicine. 90. 103658–103658.
2.
Burke, Louise, et al.. (2024). A cautionary note on pembrolizumab use in patients with ascending aortic aneurysms. European Journal of Case Reports in Internal Medicine. 11(5). 4419–4419. 3 indexed citations
3.
Santacroce, Giovanni, Brian Hayes, Yasuharu Maeda, et al.. (2024). P385 Epithelial neutrophil localization and Claudin-2 immunohistochemical "leaky gut" expression are innovative predictors of outcomes in Ulcerative Colitis patients in endoscopic remission. Journal of Crohn s and Colitis. 18(Supplement_1). i801–i803. 1 indexed citations
4.
Baker, Kevin James, et al.. (2023). IL-36 expression is increased in NSCLC with IL-36 stimulation of lung cancer cells promoting a pro-tumorigenic phenotype. Cytokine. 165. 156170–156170. 4 indexed citations
5.
Burke, Louise, et al.. (2023). Pathology of lung tumours: WHO 2021 updates and resection status. Surgery (Oxford). 41(3). 132–135. 2 indexed citations
6.
Humphreys, H., et al.. (2021). Core curriculum in pathology for future Irish medical students. Irish Journal of Medical Science (1971 -). 191(4). 1799–1807. 3 indexed citations
7.
8.
Mayer, Nick, et al.. (2021). Antiglomerular basement membrane (anti-GBM) disease with clinical and histological features that bridge the typical to atypical spectrum. BMJ Case Reports. 14(7). e241883–e241883. 4 indexed citations
9.
10.
Cullivan, Sarah, et al.. (2018). Coexistent sarcoidosis and lymphangioleiomyomatosis in a patient with cystic lung disease. Respirology Case Reports. 7(2). 1 indexed citations
11.
Kelly, Deirdre, Eamon O’Shea, Steven J. Bowe, et al.. (2017). A regional analysis of epidermal growth factor receptor (EGFR) mutated lung cancer for HSE South. Irish Journal of Medical Science (1971 -). 186(4). 855–857. 3 indexed citations
12.
Carroll, Paul, Simona Donatello, Elizabeth Connolly, et al.. (2011). Maintaining Breast Cancer Specimen Integrity and Individual or Simultaneous Extraction of Quality DNA, RNA, and Proteins from Allprotect-Stabilized and Nonstabilized Tissue Samples. Biopreservation and Biobanking. 9(4). 389–398. 23 indexed citations
13.
O’Connell, Oisin, et al.. (2010). A CF patient with progressive proteinuric renal disease: a CF-specific nodular glomerulosclerosis?. Clinical Kidney Journal. 3(4). 354–356. 4 indexed citations
14.
Weinbreck, Nicolas, J Vignaud, Hugues Bégueret, et al.. (2007). SYT-SSX fusion is absent in sarcomatoid mesothelioma allowing its distinction from synovial sarcoma of the pleura. Modern Pathology. 20(6). 617–621. 20 indexed citations
15.
Galateau-Sallé, Françoise, Richard Attanoos, A R Gibbs, et al.. (2007). Lymphohistiocytoid Variant of Malignant Mesothelioma of the Pleura: A Series of 22 Cases. The American Journal of Surgical Pathology. 31(5). 711–716. 27 indexed citations
16.
Galateau-Sallé, Françoise, J Vignaud, Louise Burke, et al.. (2004). Well-differentiated Papillary Mesothelioma of the Pleura. The American Journal of Surgical Pathology. 28(4). 534–540. 74 indexed citations
17.
Burke, Louise, András Khoór, Bruce Mackay, et al.. (1999). Alveolar adenoma: A histochemical, immunohistochemical, and ultrastructural analysis of 17 cases. Human Pathology. 30(2). 158–167. 56 indexed citations
18.
Burke, Louise, Khan Ma, Andrew N. Freedman, et al.. (1998). Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer.. PubMed. 58(12). 2533–6. 65 indexed citations
19.
Gemma, Akihiko, K. Hagiwara, Yao Ke, et al.. (1997). FHIT mutations in human primary gastric cancer.. PubMed. 57(8). 1435–7. 82 indexed citations
20.
Landers, R J, John O’Leary, Michael J. Crowley, et al.. (1993). Epstein-Barr virus in normal, pre-malignant, and malignant lesions of the uterine cervix.. Journal of Clinical Pathology. 46(10). 931–935. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nadine Francotte Breakdown of academic impact, for papers by Pietro Micheli Breakdown of academic impact, for papers by Arrigo Bondi Breakdown of academic impact, for papers by Richard Cheney Breakdown of academic impact, for papers by Amanda J. Murphy Breakdown of academic impact, for papers by Yasuyuki Mizutani Breakdown of academic impact, for papers by Elena Gallo Breakdown of academic impact, for papers by Matsuyoshi Maeda Breakdown of academic impact, for papers by Michael Goldfischer Breakdown of academic impact, for papers by Felicitas Oberndorfer
Rankless by CCL
2026